Dietary
Antioxidant Flavonoids and Risk of Coronary Heart Disease: the Zutphen
Elderly Study Flavonoids are polyphenolic antioxidants naturally present in vegetables, fruits, and beverages such as tea and wine. In vitro. flavonoids inhibit oxidation of low-density lipoprotein and reduce thrombotic tendency, but their effects on atheroscierotic complications in human being are unknown. We measured the content in various foods of the flavonoids quercetin, Kaempferol, myricetin, apigenin and tutcolin. We then assessed the flavonoid intake of 805 men aged 65-84 years in 1985 by a cross-check dietary history, the men were then followed up for 5 years. Mean baseline flavonoid intake was 25.9 mg daily. The major sources of intake were tea (61%). onions (13%) and apples (10%). Between 1985 and 1990. 43 men died of coronary heart disease. Fatal or non-fatal myocardial infarction occurred in 38 of 693 men with no history of myocardial infarction at baseline. Flavonoid intake (analysed in tertiles) was significantly inversely associated with mortality from coronary heart disease (p for trend =0.015) and showed an inverse relation with incidence of myocardial infarction. which was of borderline significance (p for trend = 0.08). The relative risk of coronary heart disease mortality in the highest versus the lowest tertile of flavonoid intake was 0.42 (95% C1.0.20-0 88). After adjustment for age. body-mass index, smoking, serum total and high-density lipoprotein cholesterol, blood pressure, physical activity, coffee consumption and intake of energy, vitamin C, vitamin E, beta-carotene, and dietary fibre, the risk was still significant (0.32(0.15-0.71). Intakes of tea, onions and apples were also inversely related to coronary heart disease mortality but these associations were weaker. Flavonoids in regularly consumed foods may reduce the risk of death from coronary heart disease in elderly men.
Background:
Epidemiological studies have indicated a protective role of dietary
flavonoids in cardiovascular disease but evidence is still conflicting.
Tea is the major dietary source for flavonoids in Western populations.
We studied the association of tea intake with aortic atherosclerosis
in a general population. The Effects
of Japanese Black Tea on Fat Crystal in Arterys The atherogenic index was found to be significantly better in rats fed a high-cholesterol diet supplemented with black tea extract than in the ones not given the extract. It was also evident that black tea inhibited the proliferation of smooth muscle cells involved in the development and progression of atherosclerosis, and suppressed the production of oxidized low-density lipoprotein, a cause of lipid accumulation. It thus seems likely that black tea has an antiatherosclerotic action. Beneficial
Effects of Tea on Cardiovascular Disease Risk Associated Factors Apolipoprotein
E (ApoE) genotype was determined in sixty-five subjects who had taken
part in a 4-week randomised crossover trial to compare the effect
of six mugs of black tea per day v. placebo on blood lipids and blood
coagulation factors. Four ApoE genotype variants (seven E2/E3, forty-five
E3/E3, twelve E3/E4 and one E4/E4) were found. ApoE allele frequency
was within the range typical for Caucasian populations (ApoE-E2 5.4%;
ApoE-E3 83.8%; ApoE-E4 10.8%). Individuals bearing at least one E4
allele had substantially higher levels of serum total cholesterol,
LDL cholesterol and triacylglycerols. Mean plasminogen activator inhibitor
(PAI-1) activity was higher in ApoE-E4 allele-bearing individuals
(E3/E4 + E4/E4, 11.89 (SE 1.27) U/ml; E3/E3, 9.19 (SE 0.80) U/ml;
E2/E3, 7.21 (SE 1.04) U/ml, P values of E4-group v. E3 and E2 being
respectively 0.093 and 0.030). These unexpected findings imply that
elevated PAI-1 activity may be a hitherto unrecognised additional
factor involved in the increased cardiovascular disease risk associated
with apoE-E4 allele. The interactions between tea drinking and genotype
were also examined. In the E3/E3 homozygotes, HDL-cholesterol was
significantly reduced in the tea period (mean placebo 1.54 mumol/l
v. mean tea 1.50 mumol/l, P = 0.027). In the E2/E3 group, triacylglycerol
concentration was significantly reduced (mean placebo 1.18 mumol/l
v. mean tea 1.09 mumol/l, P = 0.039). Tea also caused a significant
decrease of PAI-1 activity in the subjects with E2/E3 genotype (mean
placebo 7.21 U/ml v. mean tea 5.88 U/ml, P = 0.007). In the other
two genotype groups, there was no significant effect of tea. Background:
Tea has been associated with a reduced risk of cardiovascular disease.
One proposed mechanism of this risk reduction involves inhibition
of lipoprotein oxidation in vivo by antioxidant polyphenolic compounds
derived from tea. However, controlled interventions uniformly failed
to show that ingestion of tea can inhibit LDL particles from polyphenolic
compounds that are present in the aqueous phase of serum.
| |||||